---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-107566"
form_type: "8-K"
ticker: "XXII"
cik: "0001347858"
company_name: "22nd Century Group, Inc."
filed_at: "2021-08-19T23:59:59+00:00"
generated_at: "2026-06-29T08:52:39.729683+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# 22nd Century Group appoints Anthony Johnson to Board of Directors

## Summary
- Anthony Johnson appointed as Class II director effective August 18, 2021.
- Johnson is co-founder, President, CEO of Kodikaz Therapeutic Solutions and founding partner of Buffalo Biosciences.
- Will serve on Scientific, Finance and Compensation Committees; receives standard non-employee director compensation.
- Bring experience in biotechnology, genomics, and life sciences; held roles at Empire Genomics and Thermo Fisher.

## SEC filing metadata
- accession: 0001104659-21-107566
- form_type: 8-K
- ticker: XXII
- cik: 0001347858
- company_name: 22nd Century Group, Inc.
- filed_at: 2021-08-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347858/000110465921107566/0001104659-21-107566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347858/000110465921107566/tm2125456d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-107566
- JSON: https://secwatch.observer/filing/0001104659-21-107566.json
- Plain text: https://secwatch.observer/filing/0001104659-21-107566.txt

## Key facts
- Executive change
  Anthony Johnson was appointed as Director at 22nd Century Group, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Anthony Johnson, to be a director on the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1347858/000110465921107566/0001104659-21-107566-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.